Demulen 1/35 and Omalizumab Subcutaneous
Determining the interaction of Demulen 1/35 and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / ethynodiol
Brand name: Kelnor, Zovia 1/35, Zovia 1/50, Demulen 1/35, Demulen 1/50, Zovia 1/35e, Kelnor 1/50, Kelnor 1/35, Zovia 1/50e
Synonyms: Demulen 1/35 (Oral)
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Demulen 1/35-Ombitasvir, Paritaprevir, and Ritonavir
- Demulen 1/35-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Demulen 1/35-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Demulen 1/35-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Demulen 1/35-Omeclamox-Pak
- Demulen 1/35-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Demulen 1/50
- Omalizumab Subcutaneous-Denavir
- Omalizumab Subcutaneous-Denavir Topical
- Omalizumab Subcutaneous-Dendracin Neurodendraxcin
- Omalizumab Subcutaneous-Denileukin Diftitox
- Omalizumab Subcutaneous-Denorex Extra Strength